Scan Results
Daily timeframeBrenntag SE distributes chemicals and ingredients in Germany, the United States, the United Kingdom, China, Canada, Italy, Poland, France, and internationally. With a market capitalization of $8.16B, it sits in mid-cap territory. The company operates in two segments, Brenntag Essentials and Brenntag Specialties.
Market Cap
$8.16B
Beta
0.53
P/E (TTM)
35.78
P/E (Fwd)
13.36
EPS (TTM)
$1.58
EPS (Fwd)
$4.23
ROE
5.0%
ROA
3.8%
Cash
$705.0M
Total Debt
$3.38B
Free CF
$638.2M
52W Change
-4.6%
Annual Financials
Cash vs Debt
On the balance sheet, BNR.DE has $705.0M in cash with $3.38B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $638.2M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 5.0%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.8% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $14.38B (2021) to $15.17B (2025).
The relatively low beta of 0.53 suggests BNR.DE is a less volatile holding compared to the broader index. No single metric tells the full story. Reviewing BNR.DE's risk profile alongside its fundamentals and technical indicators provides a more complete picture.